he initiated a new programme on clinical proteomics at the all india institute of medical sciences in which it is intended to characterize all the proteins that are expressed during various patho/physiological conditions. the newly identified proteins will either be useful as biomarkers or they may be associated with the progression of diseases making them important targets for drug design.